Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1401 to 1450 of 2529

TitleReference numberPublishedLast updated
Vismodegib for treating basal cell carcinomaTA489
Processed nerve allografts to repair peripheral nerve discontinuitiesHTG454
Hypoglossal nerve stimulation for moderate to severe obstructive sleep apnoeaHTG455
Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxaneTA458
Tests in secondary care to identify people at high risk of ovarian cancerHTG453
Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumoursTA488
Total distal radioulnar joint replacement for symptomatic joint instability or arthritisHTG451
Extracranial to intracranial bypass for intracranial atherosclerosisHTG452
HTG EdgeSeq ALKPlus Assay EU for ALK status testing in non-small-cell lung cancerMIB128
Familial hypercholesterolaemiaQS41
Aflibercept for treating choroidal neovascularisationTA486
Sarilumab for moderate to severe rheumatoid arthritisTA485
Radiation dose monitoring software for medical imaging with ionising radiationMIB127
Sinusitis (acute): antimicrobial prescribingNG79
Cataracts in adults: managementNG77
Cystic fibrosis: diagnosis and managementNG78
Hepatitis B (chronic): diagnosis and managementCG165
PleuraFlow Active Clearance Technology for maintaining chest tube patencyMIB125
Immunosuppressive therapy for kidney transplant in adultsTA481
Immunosuppressive therapy for kidney transplant in children and young peopleTA482
Tofacitinib for moderate to severe rheumatoid arthritisTA480
Cerebral palsy in children and young peopleQS162
Child abuse and neglectNG76
Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the kneeTA477
Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphomaTA478
Reslizumab for treating severe eosinophilic asthmaTA479
Thora-3Di for assessing asthma in childrenMIB122
Memokath-028, 044 and 045 stents for urethral obstructionMIB123
FreeStyle Libre for glucose monitoringMIB110
Faltering growth: recognition and management of faltering growth in childrenNG75
Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure caused by motor neurone diseaseHTG450
Cetuximab and panitumumab for previously untreated metastatic colorectal cancerTA439
Intermediate care including reablementNG74
Caris Molecular Intelligence for guiding cancer treatmentMIB120
Type 2 diabetes: prevention in people at high riskPH38
Aptiva for painful diabetic neuropathyMIB119
High-intensity focused ultrasound for symptomatic breast fibroadenomaHTG449
Ab externo canaloplasty for primary open-angle glaucomaHTG448
Transition between inpatient mental health settings and community or care home settingsQS159
End of life care for infants, children and young peopleQS160
Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapyTA428
Pembrolizumab for treating advanced melanoma after disease progression with ipilimumabTA357
Pembrolizumab for advanced melanoma not previously treated with ipilimumabTA366
Physical health of people in prisonsQS156
HIV testing: encouraging uptakeQS157
Rehabilitation after critical illness in adultsQS158
Fertility problems: assessment and treatmentCG156
Sorafenib for treating advanced hepatocellular carcinomaTA474
Dimethyl fumarate for treating moderate to severe plaque psoriasisTA475
Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancerTA476

Results per page

  1. 10
  2. 25
  3. 50
  4. All